Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock

United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the firm's stock in a transaction that occurred on Monday, April 6th. The stock was sold at an average price of $558.41, for a total transaction of $5,304,895.00. Following the transaction, the chief executive officer directly owned 40,513 shares of